Endorphins and Opiate Antagonists in Psychiatric Research: Clinical Implications
The discovery of new molecules that function in neuronal communication can be viewed as a progression of steps beginning with the identification of the molecular structure, moving to the understanding of the mecha nisms mediating the synaptic action, and to the appraisal of the involve ment of the...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York, NY
Springer US
1982
|
| Edition: | 1st ed. 1982 |
| Subjects: | |
| Online Access: | BTU01 Volltext |
| Summary: | The discovery of new molecules that function in neuronal communication can be viewed as a progression of steps beginning with the identification of the molecular structure, moving to the understanding of the mecha nisms mediating the synaptic action, and to the appraisal of the involve ment of the new molecules in various neuronal mechanisms, and finally reaching the evaluation of this molecule's role in brain function and the consequences that are triggered by its abnormalities. Enkephalins have followed such a pattern, and the present publication expresses the salient points of the last two phases in this succession. Enkephalins were discovered in December 1975; in addition to pain threshold regulation, their participation in other brain functions was soon ascertained. Perhaps, there are multiple recognition sites for multiple molecular forms of endogenous enkephalins; similarly to other transmitter recognition sites, these are coupled with ionic and nucleotide amplifying systems; thus, when activated, they can modify membrane funtion and ionic permeability of membranes. The present publication probes the current status of our knowledge concerning the consequences related to abnormalities in enkephalin storage, release, and synthesis. However, since our basic understanding of enkephalins is incomplete, the views reported should be considered to be in a state of flux |
| Physical Description: | 1 Online-Ressource (510 p. 41 illus) |
| ISBN: | 9781468411195 |
| DOI: | 10.1007/978-1-4684-1119-5 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046871653 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 200828s1982 |||| o||u| ||||||eng d | ||
| 020 | |a 9781468411195 |9 978-1-4684-1119-5 | ||
| 024 | 7 | |a 10.1007/978-1-4684-1119-5 |2 doi | |
| 035 | |a (ZDB-2-SBE)978-1-4684-1119-5 | ||
| 035 | |a (OCoLC)903194991 | ||
| 035 | |a (DE-599)BVBBV046871653 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-634 | ||
| 082 | 0 | |a 650 |2 23 | |
| 100 | 1 | |a Shah, Nandkumar S. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Endorphins and Opiate Antagonists in Psychiatric Research |b Clinical Implications |c by Nandkumar S. Shah, Alexander G. Donald |
| 250 | |a 1st ed. 1982 | ||
| 264 | 1 | |a New York, NY |b Springer US |c 1982 | |
| 300 | |a 1 Online-Ressource (510 p. 41 illus) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a The discovery of new molecules that function in neuronal communication can be viewed as a progression of steps beginning with the identification of the molecular structure, moving to the understanding of the mecha nisms mediating the synaptic action, and to the appraisal of the involve ment of the new molecules in various neuronal mechanisms, and finally reaching the evaluation of this molecule's role in brain function and the consequences that are triggered by its abnormalities. Enkephalins have followed such a pattern, and the present publication expresses the salient points of the last two phases in this succession. Enkephalins were discovered in December 1975; in addition to pain threshold regulation, their participation in other brain functions was soon ascertained. Perhaps, there are multiple recognition sites for multiple molecular forms of endogenous enkephalins; similarly to other transmitter recognition sites, these are coupled with ionic and nucleotide amplifying systems; thus, when activated, they can modify membrane funtion and ionic permeability of membranes. The present publication probes the current status of our knowledge concerning the consequences related to abnormalities in enkephalin storage, release, and synthesis. However, since our basic understanding of enkephalins is incomplete, the views reported should be considered to be in a state of flux | ||
| 650 | 4 | |a Business and Management, general | |
| 650 | 4 | |a Business | |
| 650 | 4 | |a Management science | |
| 650 | 0 | 7 | |a Morphinantagonist |0 (DE-588)4248332-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Endorphine |0 (DE-588)4152186-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychiatrie |0 (DE-588)4047667-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1979 |z Columbia SC |2 gnd-content | |
| 689 | 0 | 0 | |a Endorphine |0 (DE-588)4152186-9 |D s |
| 689 | 0 | 1 | |a Psychiatrie |0 (DE-588)4047667-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Morphinantagonist |0 (DE-588)4248332-3 |D s |
| 689 | 1 | 1 | |a Psychiatrie |0 (DE-588)4047667-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Donald, Alexander G. |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781468411218 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780306408786 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781468411201 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4684-1119-5 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SBE |a ZDB-2-BAE | ||
| 940 | 1 | |q ZDB-2-SBE_Archiv | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032281785 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4684-1119-5 |l BTU01 |p ZDB-2-SBE |q ZDB-2-SBE_Archiv |x Verlag |3 Volltext | |
Record in the Search Index
| _version_ | 1804181719742414848 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Shah, Nandkumar S. Donald, Alexander G. |
| author_facet | Shah, Nandkumar S. Donald, Alexander G. |
| author_role | aut aut |
| author_sort | Shah, Nandkumar S. |
| author_variant | n s s ns nss a g d ag agd |
| building | Verbundindex |
| bvnumber | BV046871653 |
| collection | ZDB-2-SBE ZDB-2-BAE |
| ctrlnum | (ZDB-2-SBE)978-1-4684-1119-5 (OCoLC)903194991 (DE-599)BVBBV046871653 |
| dewey-full | 650 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 650 - Management and auxiliary services |
| dewey-raw | 650 |
| dewey-search | 650 |
| dewey-sort | 3650 |
| dewey-tens | 650 - Management and auxiliary services |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| doi_str_mv | 10.1007/978-1-4684-1119-5 |
| edition | 1st ed. 1982 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03530nmm a2200565zc 4500</leader><controlfield tag="001">BV046871653</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">200828s1982 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781468411195</subfield><subfield code="9">978-1-4684-1119-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4684-1119-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SBE)978-1-4684-1119-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)903194991</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046871653</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-634</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">650</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Shah, Nandkumar S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Endorphins and Opiate Antagonists in Psychiatric Research</subfield><subfield code="b">Clinical Implications</subfield><subfield code="c">by Nandkumar S. Shah, Alexander G. Donald</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 1982</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer US</subfield><subfield code="c">1982</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (510 p. 41 illus)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The discovery of new molecules that function in neuronal communication can be viewed as a progression of steps beginning with the identification of the molecular structure, moving to the understanding of the mecha nisms mediating the synaptic action, and to the appraisal of the involve ment of the new molecules in various neuronal mechanisms, and finally reaching the evaluation of this molecule's role in brain function and the consequences that are triggered by its abnormalities. Enkephalins have followed such a pattern, and the present publication expresses the salient points of the last two phases in this succession. Enkephalins were discovered in December 1975; in addition to pain threshold regulation, their participation in other brain functions was soon ascertained. Perhaps, there are multiple recognition sites for multiple molecular forms of endogenous enkephalins; similarly to other transmitter recognition sites, these are coupled with ionic and nucleotide amplifying systems; thus, when activated, they can modify membrane funtion and ionic permeability of membranes. The present publication probes the current status of our knowledge concerning the consequences related to abnormalities in enkephalin storage, release, and synthesis. However, since our basic understanding of enkephalins is incomplete, the views reported should be considered to be in a state of flux</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Business and Management, general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Business</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Management science</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Morphinantagonist</subfield><subfield code="0">(DE-588)4248332-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Endorphine</subfield><subfield code="0">(DE-588)4152186-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychiatrie</subfield><subfield code="0">(DE-588)4047667-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1979</subfield><subfield code="z">Columbia SC</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Endorphine</subfield><subfield code="0">(DE-588)4152186-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Psychiatrie</subfield><subfield code="0">(DE-588)4047667-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Morphinantagonist</subfield><subfield code="0">(DE-588)4248332-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Psychiatrie</subfield><subfield code="0">(DE-588)4047667-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Donald, Alexander G.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781468411218</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780306408786</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781468411201</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4684-1119-5</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBE</subfield><subfield code="a">ZDB-2-BAE</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SBE_Archiv</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032281785</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4684-1119-5</subfield><subfield code="l">BTU01</subfield><subfield code="p">ZDB-2-SBE</subfield><subfield code="q">ZDB-2-SBE_Archiv</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1979 Columbia SC gnd-content |
| genre_facet | Konferenzschrift 1979 Columbia SC |
| id | DE-604.BV046871653 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T15:15:36Z |
| indexdate | 2024-07-10T08:56:08Z |
| institution | BVB |
| isbn | 9781468411195 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032281785 |
| oclc_num | 903194991 |
| open_access_boolean | |
| owner | DE-634 |
| owner_facet | DE-634 |
| physical | 1 Online-Ressource (510 p. 41 illus) |
| psigel | ZDB-2-SBE ZDB-2-BAE ZDB-2-SBE_Archiv ZDB-2-SBE ZDB-2-SBE_Archiv |
| publishDate | 1982 |
| publishDateSearch | 1982 |
| publishDateSort | 1982 |
| publisher | Springer US |
| record_format | marc |
| spelling | Shah, Nandkumar S. Verfasser aut Endorphins and Opiate Antagonists in Psychiatric Research Clinical Implications by Nandkumar S. Shah, Alexander G. Donald 1st ed. 1982 New York, NY Springer US 1982 1 Online-Ressource (510 p. 41 illus) txt rdacontent c rdamedia cr rdacarrier The discovery of new molecules that function in neuronal communication can be viewed as a progression of steps beginning with the identification of the molecular structure, moving to the understanding of the mecha nisms mediating the synaptic action, and to the appraisal of the involve ment of the new molecules in various neuronal mechanisms, and finally reaching the evaluation of this molecule's role in brain function and the consequences that are triggered by its abnormalities. Enkephalins have followed such a pattern, and the present publication expresses the salient points of the last two phases in this succession. Enkephalins were discovered in December 1975; in addition to pain threshold regulation, their participation in other brain functions was soon ascertained. Perhaps, there are multiple recognition sites for multiple molecular forms of endogenous enkephalins; similarly to other transmitter recognition sites, these are coupled with ionic and nucleotide amplifying systems; thus, when activated, they can modify membrane funtion and ionic permeability of membranes. The present publication probes the current status of our knowledge concerning the consequences related to abnormalities in enkephalin storage, release, and synthesis. However, since our basic understanding of enkephalins is incomplete, the views reported should be considered to be in a state of flux Business and Management, general Business Management science Morphinantagonist (DE-588)4248332-3 gnd rswk-swf Endorphine (DE-588)4152186-9 gnd rswk-swf Psychiatrie (DE-588)4047667-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1979 Columbia SC gnd-content Endorphine (DE-588)4152186-9 s Psychiatrie (DE-588)4047667-4 s DE-604 Morphinantagonist (DE-588)4248332-3 s Donald, Alexander G. aut Erscheint auch als Druck-Ausgabe 9781468411218 Erscheint auch als Druck-Ausgabe 9780306408786 Erscheint auch als Druck-Ausgabe 9781468411201 https://doi.org/10.1007/978-1-4684-1119-5 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Shah, Nandkumar S. Donald, Alexander G. Endorphins and Opiate Antagonists in Psychiatric Research Clinical Implications Business and Management, general Business Management science Morphinantagonist (DE-588)4248332-3 gnd Endorphine (DE-588)4152186-9 gnd Psychiatrie (DE-588)4047667-4 gnd |
| subject_GND | (DE-588)4248332-3 (DE-588)4152186-9 (DE-588)4047667-4 (DE-588)1071861417 |
| title | Endorphins and Opiate Antagonists in Psychiatric Research Clinical Implications |
| title_auth | Endorphins and Opiate Antagonists in Psychiatric Research Clinical Implications |
| title_exact_search | Endorphins and Opiate Antagonists in Psychiatric Research Clinical Implications |
| title_exact_search_txtP | Endorphins and Opiate Antagonists in Psychiatric Research Clinical Implications |
| title_full | Endorphins and Opiate Antagonists in Psychiatric Research Clinical Implications by Nandkumar S. Shah, Alexander G. Donald |
| title_fullStr | Endorphins and Opiate Antagonists in Psychiatric Research Clinical Implications by Nandkumar S. Shah, Alexander G. Donald |
| title_full_unstemmed | Endorphins and Opiate Antagonists in Psychiatric Research Clinical Implications by Nandkumar S. Shah, Alexander G. Donald |
| title_short | Endorphins and Opiate Antagonists in Psychiatric Research |
| title_sort | endorphins and opiate antagonists in psychiatric research clinical implications |
| title_sub | Clinical Implications |
| topic | Business and Management, general Business Management science Morphinantagonist (DE-588)4248332-3 gnd Endorphine (DE-588)4152186-9 gnd Psychiatrie (DE-588)4047667-4 gnd |
| topic_facet | Business and Management, general Business Management science Morphinantagonist Endorphine Psychiatrie Konferenzschrift 1979 Columbia SC |
| url | https://doi.org/10.1007/978-1-4684-1119-5 |
| work_keys_str_mv | AT shahnandkumars endorphinsandopiateantagonistsinpsychiatricresearchclinicalimplications AT donaldalexanderg endorphinsandopiateantagonistsinpsychiatricresearchclinicalimplications |